Endothelial Dysfunction and Metabolic Effects of Nitric Oxide in Humans

[1]  K. Schulze-Osthoff,et al.  Effects of nebivolol on proliferation and apoptosis of human coronary artery smooth muscle and endothelial cells. , 2001, Cardiovascular research.

[2]  D. Bichet,et al.  Metabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patients with mild-to-moderate hypertension. , 1999, American journal of therapeutics.

[3]  J. Michaelis,et al.  Spontaneous platelet aggregation as a predictive risk factor for vascular occlusions in healthy volunteers? Results of the HAPARG Study. Haemostatic parameters as risk factors in healthy volunteers. , 1999, Atherosclerosis.

[4]  D. Tzivoni,et al.  Effect of Lipid-Lowering Therapy on Myocardial Ischemia , 1998, Cardiovascular Drugs and Therapy.

[5]  Y. Lacourciére,et al.  A DOUBLE‐BLIND CROSSOVER COMPARISON OF NEBIVOLOL AND LISINOPRIL IN THE TREATMENT OF AMBULATORY HYPERTENSION , 1994, American journal of therapeutics.

[6]  Y. Lacourciére,et al.  Placebo-controlled comparison of the effects of nebivolol and low-dose hydrochlorothiazide as monotherapies and in combination on blood pressure and lipid profile in hypertensive patients. , 1994, Journal of human hypertension.

[7]  Y. Lacourciére,et al.  Treatment of ambulatory hypertensives with nebivolol or hydrochlorothiazide alone and in combination. A randomized, double-blind, placebo-controlled, factorial-design trial. , 1994, American journal of hypertension.

[8]  A. Butler,et al.  Physiological Role of Nitric Oxide. , 1993 .

[9]  Janssens Wj.  Pharmacology of nebivolol. , 1992 .

[10]  G. Reaven.  Relationship Between Insulin Resistance and Hypertension , 1991, Diabetes Care.

[11]  S. Moncada,et al.  An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Schapiro,et al.  Platelet hyperreactivity and prognosis in survivors of myocardial infarction. , 1990, The New England journal of medicine.

[13]  W. Weichert,et al.  Spontaneous platelet aggregation and coagulation parameters as risk factors for arterial occlusions in diabetics. Results of the PARD-study. , 1986, International angiology : a journal of the International Union of Angiology.

[14]  R Busse,et al.  NO: the primary EDRF. , 1999, Journal of molecular and cellular cardiology.

[15]  W. Janssens,et al.  Animal Pharmacology of Nebivolol , 1991 .